414 related articles for article (PubMed ID: 22078297)
21. Tissue inhibitors of metalloproteinases: evolution, structure and function.
Brew K; Dinakarpandian D; Nagase H
Biochim Biophys Acta; 2000 Mar; 1477(1-2):267-83. PubMed ID: 10708863
[TBL] [Abstract][Full Text] [Related]
22. Matrix metalloproteinases (MMPs) in health and disease: an overview.
Malemud CJ
Front Biosci; 2006 May; 11():1696-701. PubMed ID: 16368548
[TBL] [Abstract][Full Text] [Related]
23. Fell-Muir Lecture: Metalloproteinases: from demolition squad to master regulators.
Murphy G
Int J Exp Pathol; 2010 Aug; 91(4):303-13. PubMed ID: 20666850
[TBL] [Abstract][Full Text] [Related]
24. Ovarian tissue remodeling: role of matrix metalloproteinases and their inhibitors.
Smith MF; Ricke WA; Bakke LJ; Dow MP; Smith GW
Mol Cell Endocrinol; 2002 May; 191(1):45-56. PubMed ID: 12044918
[TBL] [Abstract][Full Text] [Related]
25. Matrix Metalloproteinases and Tissue Inhibitors of Metalloproteinases in Echinoderms: Structure and Possible Functions.
Dolmatov IY; Nizhnichenko VA; Dolmatova LS
Cells; 2021 Sep; 10(9):. PubMed ID: 34571980
[TBL] [Abstract][Full Text] [Related]
26. Rat tail static compression model mimics extracellular matrix metabolic imbalances of matrix metalloproteinases, aggrecanases, and tissue inhibitors of metalloproteinases in intervertebral disc degeneration.
Yurube T; Takada T; Suzuki T; Kakutani K; Maeno K; Doita M; Kurosaka M; Nishida K
Arthritis Res Ther; 2012 Mar; 14(2):R51. PubMed ID: 22394620
[TBL] [Abstract][Full Text] [Related]
27. Matrix metalloproteinases and their inhibitors - pleiotropic functions in insect immunity and metamorphosis.
Vilcinskas A
FEBS J; 2022 May; 289(10):2805-2808. PubMed ID: 34904782
[TBL] [Abstract][Full Text] [Related]
28. Biochemical insights into the role of matrix metalloproteinases in regeneration: challenges and recent developments.
Bellayr IH; Mu X; Li Y
Future Med Chem; 2009 Sep; 1(6):1095-1111. PubMed ID: 20161478
[TBL] [Abstract][Full Text] [Related]
29. Metalloproteinase inhibitors: biological actions and therapeutic opportunities.
Baker AH; Edwards DR; Murphy G
J Cell Sci; 2002 Oct; 115(Pt 19):3719-27. PubMed ID: 12235282
[TBL] [Abstract][Full Text] [Related]
30. Crystal structures of MMPs in complex with physiological and pharmacological inhibitors.
Maskos K
Biochimie; 2005; 87(3-4):249-63. PubMed ID: 15781312
[TBL] [Abstract][Full Text] [Related]
31. The Role of the Metzincin Superfamily in Prostate Cancer Progression: A Systematic-Like Review.
Binder MJ; Ward AC
Int J Mol Sci; 2021 Mar; 22(7):. PubMed ID: 33808504
[TBL] [Abstract][Full Text] [Related]
32. Reactive site mutations in tissue inhibitor of metalloproteinase-3 disrupt inhibition of matrix metalloproteinases but not tumor necrosis factor-alpha-converting enzyme.
Wei S; Kashiwagi M; Kota S; Xie Z; Nagase H; Brew K
J Biol Chem; 2005 Sep; 280(38):32877-82. PubMed ID: 16079149
[TBL] [Abstract][Full Text] [Related]
33. Role of the netrin-like domain of procollagen C-proteinase enhancer-1 in the control of metalloproteinase activity.
Bekhouche M; Kronenberg D; Vadon-Le Goff S; Bijakowski C; Lim NH; Font B; Kessler E; Colige A; Nagase H; Murphy G; Hulmes DJ; Moali C
J Biol Chem; 2010 May; 285(21):15950-9. PubMed ID: 20207734
[TBL] [Abstract][Full Text] [Related]
34. Matrix metalloproteases and their inhibitors are produced by overlapping populations of activated astrocytes.
Muir EM; Adcock KH; Morgenstern DA; Clayton R; von Stillfried N; Rhodes K; Ellis C; Fawcett JW; Rogers JH
Brain Res Mol Brain Res; 2002 Apr; 100(1-2):103-17. PubMed ID: 12008026
[TBL] [Abstract][Full Text] [Related]
35. A Disintegrin and Metalloproteinase (ADAM) and ADAM with thrombospondin motifs (ADAMTS) family in vascular biology and disease.
Zhong S; Khalil RA
Biochem Pharmacol; 2019 Jun; 164():188-204. PubMed ID: 30905657
[TBL] [Abstract][Full Text] [Related]
36. Quantitative Mass Spectrometry-Based Secretome Analysis as a Tool to Investigate Metalloprotease and TIMP Activity.
Yang CY; Troeberg L; Scilabra SD
Methods Mol Biol; 2020; 2043():265-273. PubMed ID: 31463919
[TBL] [Abstract][Full Text] [Related]
37. Metalloproteinases and their tissue inhibitors in Alzheimer's disease and other neurodegenerative disorders.
Rivera S; García-González L; Khrestchatisky M; Baranger K
Cell Mol Life Sci; 2019 Aug; 76(16):3167-3191. PubMed ID: 31197405
[TBL] [Abstract][Full Text] [Related]
38. TIMPs and cardiac remodeling: 'Embracing the MMP-independent-side of the family'.
Vanhoutte D; Heymans S
J Mol Cell Cardiol; 2010 Mar; 48(3):445-53. PubMed ID: 19799912
[TBL] [Abstract][Full Text] [Related]
39. Expression profiling of metalloproteinases and their inhibitors in synovium and cartilage.
Davidson RK; Waters JG; Kevorkian L; Darrah C; Cooper A; Donell ST; Clark IM
Arthritis Res Ther; 2006; 8(4):R124. PubMed ID: 16859525
[TBL] [Abstract][Full Text] [Related]
40. Evidence for a role of matrix metalloproteinases and their inhibitors in primordial germ cell migration.
Díez-Torre A; Díaz-Núñez M; Eguizábal C; Silván U; Aréchaga J
Andrology; 2013 Sep; 1(5):779-86. PubMed ID: 23843195
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
